GENB stock jumps to a new 52-week high—see key levels, RSI, volume, short interest, and Phase 3 GB-0895 updates plus analyst ...
26don MSN
This Is Nvidia CEO Jensen Huang's Favorite Biotech Stock -- and You've Probably Never Heard of It
Generate Biomedicines focuses on AI-enabled drug discovery.
Nvidia Corp‘s GPUs have become the backbone of artificial intelligence, but they won’t be enough to determine the winners in ...
Multi-year collaboration will facilitate the co-development of optimized therapeutics that bind to challenging targets in ways traditional techniques cannot SOMERVILLE, Mass. & HOUSTON--(BUSINESS WIRE ...
Generate’s latest capital raise was $1.5 billion in new capital commitments from global institutional investors such as CalSTRS, HESTA, QIC and AustralianSuper Based in San Francisco, Generate Capital ...
Generate, the management/TV and digital production company launched in 2006 by Jordan Levin, Pete Aronson, Dave Rath and Kara Welker, has been acquired by Alloy Digital, a division of youth-focused ...
SAN FRANCISCO--(BUSINESS WIRE)--Generate Capital, PBC, a leading sustainable infrastructure investment platform and operating company, today announced that it has named Brian Lehman as Chief Financial ...
Cambridge biotech Generate Biomedicines said Thursday it has raised $370 million in venture capital from investors keen on its plan to use machine learning in drug discovery, money that will enable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results